Why Medical Product Cos. Must watch the Dobbs decision


By Eric Alexander (June 16, 2022, 6:29 p.m. EDT) – Even for those of us whose practice and writing focus on product liability law and other things that matter to manufacturers of medical products, the apparent pending quashing of Roe v. Wade in Dobbs v. Jackson Women’s Health Organization pending before the United States Supreme Court is hard to ignore.[1]

Without even entering the body of law leading and arising from Roe[2] or principles of case law, it is evident that the impacts of the Dobbs decision, assuming the disclosed draft reflects the final opinion, will be profound and far-reaching.

On the one hand, the real possibility of significant…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

Previous One More Gate is a strategic deck builder set in the Wakfu universe – GameSpace.com
Next Can phentermine cause heart failure? Risks, long-term effects and more